79 related articles for article (PubMed ID: 34033285)
21. BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm.
Silver JA; Bogatchenko M; Pusztaszeri M; Forest VI; Hier MP; Yang JW; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Nov; 50(1):63. PubMed ID: 34742355
[TBL] [Abstract][Full Text] [Related]
22. BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer.
Ehlers M; Schmidt M; Mattes-Gyorgy K; Antke C; Enczmann J; Schlensog M; Japp A; Haase M; Allelein S; Dringenberg T; Giesel F; Esposito I; Schott M
Horm Metab Res; 2022 Dec; 54(12):852-858. PubMed ID: 36427494
[TBL] [Abstract][Full Text] [Related]
23. BRAF
Gao Y; Xiang D; Li W; Zheng X; Wang L; Li Z; Chen T
Front Endocrinol (Lausanne); 2022; 13():843334. PubMed ID: 35651980
[No Abstract] [Full Text] [Related]
24. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Tao Y; Wang F; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Zhao S; Wang Y; Xing M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3228-3238. PubMed ID: 34273152
[TBL] [Abstract][Full Text] [Related]
25. Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.
Liu X; Liu H; Wang L; Han Y; Kong L; Zhang X
Diagn Pathol; 2024 Feb; 19(1):29. PubMed ID: 38341587
[TBL] [Abstract][Full Text] [Related]
26. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.
Zhang X; Zhong Y; Liu L; Jia C; Cai H; Yang J; Wu B; Lv Z
Cell Death Dis; 2023 Dec; 14(12):827. PubMed ID: 38092752
[TBL] [Abstract][Full Text] [Related]
27. Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids.
Lasolle H; Schiavo A; Tourneur A; Gillotay P; de Faria da Fonseca B; Ceolin L; Monestier O; Aganahi B; Chomette L; Kizys MML; Haenebalcke L; Pieters T; Goossens S; Haigh J; Detours V; Maia ALS; Costagliola S; Romitti M
Oncogene; 2024 Jan; 43(3):155-170. PubMed ID: 37985676
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification of papillary thyroid cancers using multidimensional machine learning.
Li Y; Wu F; Ge W; Zhang Y; Hu Y; Zhao L; Gou W; Shi J; Ni Y; Li L; Fu W; Lin X; Yu Y; Han Z; Chen C; Xu R; Zhang S; Zhou L; Pan G; Peng Y; Mao L; Zhou T; Zheng J; Zheng H; Sun Y; Guo T; Luo D
Int J Surg; 2024 Jan; 110(1):372-384. PubMed ID: 37916932
[TBL] [Abstract][Full Text] [Related]
29. The Relationship between Thyrotropin Serum Concentrations and Thyroid Carcinoma.
Zhang X; Tian L; Teng D; Teng W
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894384
[TBL] [Abstract][Full Text] [Related]
30. Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective.
Pitoia F; Scheffel RS; Califano I; Gauna A; Tala H; Vaisman F; Gonzalez AR; Hoff AO; Maia AL
Rev Endocr Metab Disord; 2024 Feb; 25(1):109-121. PubMed ID: 37380825
[TBL] [Abstract][Full Text] [Related]
31. Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?
Kościuszko M; Buczyńska A; Krętowski AJ; Popławska-Kita A
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370792
[TBL] [Abstract][Full Text] [Related]
32. BRAF
Choi JH; Yu HW; Lee JK; Kim W; Choi JY; Na HY; Park SY; Ahn CH; Moon JH; Choi SI; Lee HY; Lee WW; Cha W; Jeong WJ
World J Surg Oncol; 2023 Feb; 21(1):49. PubMed ID: 36804879
[TBL] [Abstract][Full Text] [Related]
33. The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.
Lei Y; Zhao X; Feng Y; He D; Hu D; Min Y
Cancer Control; 2023; 30():10732748231155701. PubMed ID: 36744396
[TBL] [Abstract][Full Text] [Related]
34. The Presence of Typical "BRAFV600E-Like" Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation.
Turchini J; Sioson L; Clarkson A; Sheen A; Delbridge L; Glover A; Sywak M; Sidhu S; Gill AJ
Endocr Pathol; 2023 Mar; 34(1):112-118. PubMed ID: 36709221
[TBL] [Abstract][Full Text] [Related]
35. LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis.
Song X; Chen Y; Peng Y; Wang X; Zheng S; Shi F; Lan J
Evid Based Complement Alternat Med; 2022; 2022():2295044. PubMed ID: 36248434
[TBL] [Abstract][Full Text] [Related]
36. Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).
Ward LS; Scheffel RS; Hoff AO; Ferraz C; Vaisman F
Arch Endocrinol Metab; 2022 Sept 08; 66(4):522-532. PubMed ID: 36074944
[TBL] [Abstract][Full Text] [Related]
37. Correlation of the Expression of BRAF V600E Mutation With Various Phenotypic Expressions of Thyroid Neoplasms.
Harikrishnan V; Kumari S; Ramkumar S; Sankaran R; Ramalingam S; Sairam T
Cureus; 2021 Jun; 13(6):e16048. PubMed ID: 34345541
[TBL] [Abstract][Full Text] [Related]
38. The BRAF
Scheffel RS; de Cristo AP; Romitti M; Vargas CVF; Ceolin L; Zanella AB; Dora JM; Maia AL
Arch Endocrinol Metab; 2021 May; 64(6):751-757. PubMed ID: 34033285
[TBL] [Abstract][Full Text] [Related]
39. The Role of American Thyroid Association Pediatric Thyroid Cancer Risk Stratification and
Giles Şenyürek Y; İşcan Y; Sormaz İC; Poyrazoğlu Ş; Tunca F
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):196-206. PubMed ID: 35135184
[TBL] [Abstract][Full Text] [Related]
40. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
